RAPP
Rapport Therapeutics Inc.
$28.93
+$2.05(+7.63%)
61
Overall
60
Value
63
Tech
--
Quality
Market Cap
$1.06B
Volume
415.30K
52W Range
$6.43 - $42.27
Target Price
$51.71
Key Metrics Overview
| Market Cap | $1.06B | P/E Ratio | N/A |
| 52W High | $42.27 | 52W Low | $6.43 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 62.8% |
| Overall Score | 61 | Value Score | 60 |
| Quality Score | -- | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-3.01 | EPS Next Est | $-3.88 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RAPP | $28.93 | +7.6% | 415.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rapport Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW